$20 Million in Liquid Assets Support Rapid Growth Including Acquisitions, Bio Pharma Production and Nanotechnology Initiatives for Diversified Global Heath Leader Cosmos Health, Inc. (Nasdaq: COSM)

Published: June 10, 2026 · Associated Press

$65.3 Million 2025 Revenue Reported Followed by Q1 2026 Record of $17.9 Million Portfolio of Proprietary Pharmaceutical and Nutraceutical Brands, Including Sky Premium Life®, Mediterranation®, bio-bebe®, C-Sept® and C-Scrub®.